Literature DB >> 10190301

Epidermal participation in post-burn hypertrophic scar development.

T E Hakvoort1, V Altun, R S Ramrattan, T H van der Kwast, R Benner, P P van Zuijlen, A F Vloemans, E P Prens.   

Abstract

The reconstruction of epidermal architecture over time in normotrophic and hypertrophic scars in untransplanted, spontaneously healed partial-thickness burns has scarcely been studied, unlike the regeneration of epidermal grafts used to cover burn wounds and the regeneration of the dermis during hypertrophic scarring. The expression of markers of epidermal proliferation, differentiation and activation in normotrophic and hypertrophic scars in spontaneously healed partial-thickness burns was assessed and compared with the expression of these markers in normal control skin of healthy persons to determine whether hypertrophic scarring is associated with abnormalities in the phenotype of keratinocytes. Punch biopsies were taken both of partial-thickness burns after re-epithelialisation and of matched unburned skin. At 4 and 7 months post-burn, biopsies were taken of normotrophic and hypertrophic scars that had developed in these wounds. The biopsies were analysed using immunostaining for markers of keratinocyte proliferation, differentiation and activation (keratins 5, 10, 16 and 17, filaggrin, transglutaminase and CD36). We observed a higher expression of markers for proliferation, differentiation and activation in the epidermis of scars at 1 month post-burn than in normal control skin of healthy persons. There was a striking difference between normotrophic and hypertrophic scars at 4 months post-burn. Keratinocytes in hypertrophic scars displayed a higher level of proliferation, differentiation and activation than did normotrophic scars. At 7 months post-burn all keratinocyte proliferation and differentiation markers showed normal expression, but the activation marker CD36 remained upregulated in both normotrophic and hypertrophic scars. Surprisingly, in matched unburned skin of burn patients, a state of hyperactivation was observed at 1 month. Our results suggest that keratinocytes may be involved in the pathogenesis of hypertrophic scarring.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10190301     DOI: 10.1007/s004280050331

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  6 in total

1.  Gelatin-based anionic hydrogel as biocompatible substrate for human keratinocyte growth.

Authors:  Filippo Renò; Manuela Rizzi; Mario Cannas
Journal:  J Mater Sci Mater Med       Date:  2011-12-13       Impact factor: 3.896

2.  Histology of the thick scar on the female, red Duroc pig: final similarities to human hypertrophic scar.

Authors:  Nobuyuki Harunari; Kathy Q Zhu; Rebecca T Armendariz; Heike Deubner; Pornprom Muangman; Gretchen J Carrougher; F Frank Isik; Nicole S Gibran; Loren H Engrav
Journal:  Burns       Date:  2006-08-14       Impact factor: 2.744

3.  JUN promotes hypertrophic skin scarring via CD36 in preclinical in vitro and in vivo models.

Authors:  Michelle F Griffin; Mimi R Borrelli; Julia T Garcia; Michael Januszyk; Megan King; Tristan Lerbs; Lu Cui; Alessandra L Moore; Abra H Shen; Shamik Mascharak; Nestor M Diaz Deleon; Sandeep Adem; Walter L Taylor; Heather E desJardins-Park; Marc Gastou; Ronak A Patel; Bryan A Duoto; Jan Sokol; Yuning Wei; Deshka Foster; Kellen Chen; Derrick C Wan; Geoffrey C Gurtner; Hermann P Lorenz; Howard Y Chang; Gerlinde Wernig; Michael T Longaker
Journal:  Sci Transl Med       Date:  2021-09-01       Impact factor: 17.956

4.  Scar formation following excisional and burn injuries in a red Duroc pig model.

Authors:  Britani N Blackstone; Jayne Y Kim; Kevin L McFarland; Chandan K Sen; Dorothy M Supp; J Kevin Bailey; Heather M Powell
Journal:  Wound Repair Regen       Date:  2017-07-31       Impact factor: 3.617

5.  Hypertrophic Scars: Are Vitamins and Inflammatory Biomarkers Related with the Pathophysiology of Wound Healing?

Authors:  Inês Correia-Sá; Paula Serrão; Marisa Marques; Maria A Vieira-Coelho
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

6.  Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology.

Authors:  N Jumper; T Hodgkinson; R Paus; A Bayat
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.